Company intelligence / Profile preview

Swiss Pharma

Ownership: Private
Development stage: Commercial

Overview

Swiss Pharma, also known as The Swiss Family, offers a wide range of high-quality and affordable generic medicine brands across the globe. No specific clinical trial results are mentioned; focus is on commercialized products.[4]

Therapeutic areas: Other
Modalities: Small molecules (focus on generic medicines suggests small molecule drugs)[4]
Industry: Biotech

Beyond the preview

Go deeper on Swiss Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swiss Pharma.